# IV Ascorbic Acid in Advanced Gastric Cancer

> **NCT03015675** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** ascorbic acid
- **DRUG:** mFOLFOX6

## Key facts

- **NCT ID:** NCT03015675
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-12
- **Primary completion:** 2017-12
- **Final completion:** 2019-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015675, "IV Ascorbic Acid in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03015675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*